Reducing rehospitalization in cardiac patients: a randomized, controlled trial of a cardiac care management program ("Cardiolotse") in Germany.

IF 7 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL
Wiebke Schüttig, Harald Darius, Katrin C Reber, Marie Coors, Amelie Flothow, Alfred Holzgreve, Sebastian Karmann, Anica Stürtz, Rebecca Zöller, Saskia Kropp, Petra Riesner, Leonie Sundmacher
{"title":"Reducing rehospitalization in cardiac patients: a randomized, controlled trial of a cardiac care management program (\"Cardiolotse\") in Germany.","authors":"Wiebke Schüttig, Harald Darius, Katrin C Reber, Marie Coors, Amelie Flothow, Alfred Holzgreve, Sebastian Karmann, Anica Stürtz, Rebecca Zöller, Saskia Kropp, Petra Riesner, Leonie Sundmacher","doi":"10.1186/s12916-024-03691-7","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>We conducted a prospective, randomized, controlled, two-group parallel trial investigating the effectiveness of a care management program employing cardiac care navigators providing post-discharge support to patients compared to standard care.</p><p><strong>Methods: </strong>The intervention commenced in 2019/2020 for 2862 patients hospitalized with heart failure, coronary heart disease, or cardiac arrhythmias in departments of cardiology across eight participating sites of a hospital group in Berlin, Germany. We analyzed the results using an intention-to-treat approach. The primary outcome was the all-cause rehospitalization rate after 12 months. Secondary outcomes included rehospitalizations due to one of the qualifying cardiac diagnoses, duration of rehospitalization, mortality, health-related quality of life, and several process indicators. Trial data were collected from a combination of face-to-face and phone interviews conducted by hospital staff throughout the 12-month follow-up period using standardized questionnaires. Administrative claims data were provided by a large statutory health insurer. Outcomes for the intervention and control groups were compared using logistic regression, generalized linear models (GLMs) with a negative binomial distribution, ordinary least squares, and Cox proportional hazards regression.</p><p><strong>Results: </strong>Compared to the control group (N = 1294), the intervention group (N = 1256) had a lower rate of all-cause rehospitalizations (62.6% vs. 66.4%, p = 0.05) and shorter lengths of stay (14.49 vs. 16.89 days, p = 0.02) during the 12-month follow-up period. These differences were also present for rehospitalizations due to the cardiac diseases qualifying for study recruitment, with rehospitalization rates for the intervention and control groups being 58.0% vs. 61.4% (p = 0.08) and particularly pronounced for lengths of rehospitalization stay of 12.97 vs. 15.40 days (p = 0.01), respectively. Subgroup analyses indicated positive effects of the intervention for patients 70 years and older (p = 0.05), females (p = 0.06), and those with little or no German language proficiency (p = 0.03). Furthermore, we found positive effects on patients' adherence to health-related behavioral recommendations (81.91% vs. 73.95%, p = 0.000).</p><p><strong>Conclusions: </strong>This study adds to the body of evidence indicating that care management interventions supporting patients as they transition from the inpatient to the outpatient sector can lower rehospitalizations, decrease length of rehospitalization stays, and improve adherence to post-discharge recommendations.</p><p><strong>Trial registration: </strong>German Clinical Trial Register, DRKS00020424 . Registered 2020-06-18. (retrospectively registered).</p>","PeriodicalId":9188,"journal":{"name":"BMC Medicine","volume":"22 1","pages":"480"},"PeriodicalIF":7.0000,"publicationDate":"2024-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11492482/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12916-024-03691-7","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background: We conducted a prospective, randomized, controlled, two-group parallel trial investigating the effectiveness of a care management program employing cardiac care navigators providing post-discharge support to patients compared to standard care.

Methods: The intervention commenced in 2019/2020 for 2862 patients hospitalized with heart failure, coronary heart disease, or cardiac arrhythmias in departments of cardiology across eight participating sites of a hospital group in Berlin, Germany. We analyzed the results using an intention-to-treat approach. The primary outcome was the all-cause rehospitalization rate after 12 months. Secondary outcomes included rehospitalizations due to one of the qualifying cardiac diagnoses, duration of rehospitalization, mortality, health-related quality of life, and several process indicators. Trial data were collected from a combination of face-to-face and phone interviews conducted by hospital staff throughout the 12-month follow-up period using standardized questionnaires. Administrative claims data were provided by a large statutory health insurer. Outcomes for the intervention and control groups were compared using logistic regression, generalized linear models (GLMs) with a negative binomial distribution, ordinary least squares, and Cox proportional hazards regression.

Results: Compared to the control group (N = 1294), the intervention group (N = 1256) had a lower rate of all-cause rehospitalizations (62.6% vs. 66.4%, p = 0.05) and shorter lengths of stay (14.49 vs. 16.89 days, p = 0.02) during the 12-month follow-up period. These differences were also present for rehospitalizations due to the cardiac diseases qualifying for study recruitment, with rehospitalization rates for the intervention and control groups being 58.0% vs. 61.4% (p = 0.08) and particularly pronounced for lengths of rehospitalization stay of 12.97 vs. 15.40 days (p = 0.01), respectively. Subgroup analyses indicated positive effects of the intervention for patients 70 years and older (p = 0.05), females (p = 0.06), and those with little or no German language proficiency (p = 0.03). Furthermore, we found positive effects on patients' adherence to health-related behavioral recommendations (81.91% vs. 73.95%, p = 0.000).

Conclusions: This study adds to the body of evidence indicating that care management interventions supporting patients as they transition from the inpatient to the outpatient sector can lower rehospitalizations, decrease length of rehospitalization stays, and improve adherence to post-discharge recommendations.

Trial registration: German Clinical Trial Register, DRKS00020424 . Registered 2020-06-18. (retrospectively registered).

减少心脏病患者再次住院:德国心脏护理管理计划("Cardiolotse")随机对照试验。
研究背景我们开展了一项前瞻性、随机对照、两组平行试验,研究了采用心脏护理导航员为患者提供出院后支持的护理管理项目与标准护理相比的效果:干预于2019/2020年开始,对象为德国柏林一家医院集团的8个参与地点的心脏病科住院的2862名心力衰竭、冠心病或心律失常患者。我们采用意向治疗法对结果进行了分析。主要结果是12个月后的全因再住院率。次要结果包括因符合条件的心脏病诊断之一导致的再住院率、再住院时间、死亡率、与健康相关的生活质量以及多项流程指标。在为期 12 个月的随访期间,医院工作人员使用标准化问卷,通过面对面访谈和电话访谈相结合的方式收集试验数据。行政索赔数据由一家大型法定医疗保险公司提供。采用逻辑回归、负二项分布广义线性模型(GLMs)、普通最小二乘法和考克斯比例危险回归对干预组和对照组的结果进行了比较:与对照组(1294 人)相比,干预组(1256 人)的全因再住院率较低(62.6% 对 66.4%,P=0.05),随访 12 个月期间的住院时间较短(14.49 天对 16.89 天,P=0.02)。干预组和对照组的再住院率分别为 58.0% 和 61.4%(p = 0.08),再住院时间分别为 12.97 天和 15.40 天(p = 0.01),差异尤为明显。分组分析表明,干预对 70 岁及以上患者(p = 0.05)、女性(p = 0.06)以及德语水平较低或没有德语水平的患者(p = 0.03)有积极影响。此外,我们还发现该疗法对患者遵守与健康相关的行为建议产生了积极影响(81.91% vs. 73.95%,p = 0.000):这项研究补充了大量证据,表明在患者从住院病人向门诊病人过渡的过程中,支持他们的护理管理干预措施可以降低再住院率、缩短再住院时间并提高出院后建议的依从性:试验注册:德国临床试验注册中心,DRKS00020424 。注册时间:2020-06-18。(回顾性注册)。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
BMC Medicine
BMC Medicine 医学-医学:内科
CiteScore
13.10
自引率
1.10%
发文量
435
审稿时长
4-8 weeks
期刊介绍: BMC Medicine is an open access, transparent peer-reviewed general medical journal. It is the flagship journal of the BMC series and publishes outstanding and influential research in various areas including clinical practice, translational medicine, medical and health advances, public health, global health, policy, and general topics of interest to the biomedical and sociomedical professional communities. In addition to research articles, the journal also publishes stimulating debates, reviews, unique forum articles, and concise tutorials. All articles published in BMC Medicine are included in various databases such as Biological Abstracts, BIOSIS, CAS, Citebase, Current contents, DOAJ, Embase, MEDLINE, PubMed, Science Citation Index Expanded, OAIster, SCImago, Scopus, SOCOLAR, and Zetoc.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信